Skip to Content

New Haven Pharmaceuticals, Inc.

New Haven Pharmaceuticals, Inc. Espero Pharmaceuticals Inc. has acquired worldwide rights to New Haven Pharmaceuticals Inc.’s FDA-approved Durlaza (aspirin) extended-release capsules. February 2017.

See: Espero Biopharma

Hide